GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 23.75
-1.05 (-4.23%)
Mar 4, 2026, 10:20 AM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.68 billion as of March 3, 2026. Its market cap has increased by 2.69% in one year.
Market Cap
2.68B
Enterprise Value
2.45B
Revenue
36.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.75
Market Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.68B, an increase of 78.01%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.68B | -3.69% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.50B |
| Shine-On BioMedical | 3.29B |
| SYN-TECH Chem. & Pharm. | 3.27B |
| Syngen Biotech | 3.25B |
| 3D Global Biotech | 3.14B |
| Apex Biotechnology | 3.02B |
| Sunny Pharmtech | 2.75B |
| Synbio Tech | 2.73B |